tothemoon, interesting company, the Israeli ARK fund owns a sizable stake in this reprogramming of macrophages. ARK had been buying more every day for a while now. The company just announced a new patent too.

The immune modulation is directly in line with the end result of leronlimab.

Wake me up when a fund like ARK starts buying CYDY, that will create an honest and true fireworks display around here.